Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Allogeneic Virus-specific T-lymphocytes R-MVST

Review the clinical trials studying allogeneic virus-specific t-lymphocytes r-mvst on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-2 of 2

Haploidentical Viral-Specific T-Cells for Treatment of Patients with Refractory Cytomegalovirus and/or Adenovirus Infections after Hematopoietic Cell Transplantation
Status: Active
Location: Saint Jude Children's Research Hospital, Memphis, Tennessee
Allogeneic Virus-Specific T-lymphocyte Infusion for the Treatment of Patients with Epstein-Barr Virus, Cytomegalovirus, Adenovirus, or BK Virus Infection
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York